Rectal Adenocarcinoma

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,

Active, not recruiting
  • Colon Adenocarcinoma
  • +18 more
  • Cetuximab
  • +5 more
  • Anchorage, Alaska
  • +797 more
Jan 9, 2023

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States

Active, not recruiting
  • Rectal Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +649 more
Aug 5, 2022

Rectal Adenocarcinoma Trial in Dallas (Radiation, Bavituximab, Capecitabine)

Completed
  • Rectal Adenocarcinoma
  • Radiation
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Aug 19, 2020

Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in United States (biological, drug,

Completed
  • Rectal Adenocarcinoma
  • +2 more
  • Bevacizumab
  • +6 more
  • Birmingham, Alabama
  • +106 more
Mar 13, 2019